Canadian court favors Pfizer in Lipitor case against Ranbaxy

09/14/2007 | Forbes

A Canadian court has handed out a decision preventing Indian drug giant Ranbaxy Laboratories Ltd. from selling a generic version of Pfizer's cholesterol-lowering drug Lipitor. At issue is a crystalline form of atorvastatin, an active ingredient in Lipitor, to which Pfizer has exclusive rights until 2016.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN